The Envelope Please, and the ‘Phlemmy’ Goes to . . .

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 6 No 10
Volume 6
Issue 10

PASADENA, Calif-The Emmy Awards, honoring television’s best shows, may be more prestigious, but the Phlemmy Awards are gaining popularity, if not with television executives, then certainly with antismoking crusaders.

PASADENA, Calif—The Emmy Awards, honoring television’s best shows, may be more prestigious, but the Phlemmy Awards are gaining popularity, if not with television executives, then certainly with antismoking crusaders.

The American Lung Association bestows the dubious awards on productions that feature use of tobacco products in a glamorous or positive way. This year’s winners included Seinfeld for Kramer’s smoking escapades (he gets kicked out of a restaurant for smoking, then gives a smoking party in his apartment); Cybill for an episode in which the female lead lights up a cigar; and NYPD Blue for a scene in which a cop softens up a suspect by offering him a smoke.

The corresponding Pink Lung award for shows that avoid smoking or portray it in a negative light went to Chicago Hope, Touched by an Angel, and Spin City.

Recent Videos
According to Aditya Bardia, MD, MPH, FASCO, antibody-drug conjugates are slowly replacing chemotherapy as a standard treatment for breast cancer.
A simulation procedure helped to ascertain chemotherapy tolerability before administering radioembolization therapy for NETs with liver metastases.
The addition of radioembolization to radiosensitizing chemotherapy may help concurrently treat patients with liver tumors and disease outside the liver.
In neuroendocrine tumor management, patients with insulinoma may be at risk of severe hypoglycemia following receipt of GLP-1 receptor agonists.
Decreasing the low-dose bath of proton therapy to the body may limit the impact of radiation on lymphocytes and affect tumor response.
4 experts are featured in this series.
4 experts are featured in this series.
According to Eyub Akdemir, MD, reducing EDIC may be feasible without compromising target coverage to reduce anticipated lymphopenia rates.
7 experts are featured in this series.
Related Content